About My Health Careers Internship MedBlogs Contact us

New Cancer-Causing Pathway Identified That Causes Leukemia

by Bidita Debnath on October 4, 2017 at 11:47 PM
Font : A-A+

 New Cancer-Causing Pathway Identified That Causes Leukemia

A person who has leukemia suffers from an abnormal production of blood cells, generally leukocytes (white blood cells). Massachusetts General Hospital (MGH) investigators have identified a new cancer-causing pathway behind most cases of an aggressive type of leukemia, findings that could lead to new targeted treatment approaches.

In the report published online in Cancer Discovery, the team describes finding a protein called TOX (thymocyte selection-associated high mobility box protein) that acts in concert with other oncogenes to initiate the development of T-cell acute lymphoblastic leukemia (T-ALL). Expressed in 95 percent of human T-ALL cases, TOX is also required for the cancer's growth and persistence.


"Despite the ability of front-line chemotherapy to induce remission in T-ALL, in many patients the cancer either does not respond to treatment or relapses after a first remission," says David Langenau, PhD, of the MGH Molecular Pathology Unit and the MGH Cancer Center, senior author of the report. "Sadly, 70 percent of children and more than 90 percent of adults with treatment-resistant or relapsed T-ALL eventually succumb to their disease. Treatment resistance remains the greatest clinical challenge, which makes identifying common mechanisms that drive cancer growth a major imperative."

T-ALL has several molecular subtypes, many driven by common oncogenes such as MYC and NOTCH, yet evidence has suggested that the cancer's initiation is likely driven by aberrations in DNA repair. Using an innovative zebrafish model of T-ALL, lead author Riadh Lobbardi, PhD, of the MGH Molecular Pathology Unit and colleagues revealed that TOX works in collaboration with known oncogene pathways to transform T-cell precursors into leukemia cells by altering DNA repair and then expanding the population of transformed cells.

The team's experiments revealed that TOX altered DNA repair and initiated genome instability in zebrafish T-ALL and in mouse cells. In human T-ALL cells, TOX was shown to suppress non-homologous end joining (NHEJ) repair, an important pathway required for repairing double-strand DNA breaks that when disrupted is known to cause errant DNA repair and genomic instability. Practically all tested samples of human T-ALL were found to express TOX, which was also found to be essential for the proliferation and survival of human T-ALL in both cultured cells and in tumors implanted into mice.

Langenau explains that TOX is known to have important roles in the development and maturation of several types of immune cells, yet its roles in leukemia initiation and genomic instability were not described until this work. TOX is one of a group of proteins known to regulate the configuration or expression of genes by binding to DNA molecules, yet its mechanism in T-ALL - blocking NHEJ repair by binding to DNA repair proteins rather than directly to DNA - was totally unexpected.

"A major role for TOX in T-ALL is to elicit defects in DNA repair leading to genetic changes that drive normal cells into cancer," he says. "TOX then continues to be expressed within leukemic cells and is required for continued tumor growth. That means that, if we can successfully target TOX with small molecules in the future, the 95 percent of T-ALL patients whose tumors express TOX would have new treatment options for this aggressive leukemia." In addition to better understanding how TOX regulates the continued growth of T-ALL, it also will be important to determine whether related TOX proteins have similar cancer-causing molecular functions in other types of cancers.

Source: Eurekalert

News A-Z
News Category
What's New on Medindia
Menstrual Disorders
Coffee May Help You Fight Endometrial Cancer
Fermented Skin Care
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Leukemia Chronic Myeloid Leukemia Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Multiple Myeloma Bone Marrow Transplantation Hairy Cell Leukemia 

Recommended Reading
Revolutionary New Therapy for a Deadly Form of Leukemia
A revolutionary new therapy for a deadly form of leukemia, an approach whose development has also .....
Capicua Gene Inactivation Causes T-cell Acute Lymphoblastic Leukemia
Capicua gene when inactivated, it inevitably leads to T-cell acute lymphoblastic leukaemia. The ......
World Chronic Myeloid Leukemia Day: Today, Together We are Treated, Tomorrow We Need Cure
World Chronic Myeloid Leukemia Day is celebrated on 22nd September because 9/22 represents the ......
Antibiotic May Reduce Infection Risk in Leukemia Patients
Leukemia occurs most often in adults older than 55 years, but it is also the most common cancer in ....
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lympho...
Acute Myeloid Leukemia
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukem...
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by ex...
Hairy Cell Leukemia
Hairy cell leukemia (HCL) is a type of leukemia where there are increased numbers of abnormal B-lymp...
Encyclopedia section of medindia gives general information about Leukemia...
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Meh...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)